MRP2 (ABCC2) and disorders of bilirubin handling in liver

Hepatobiliary Transport in Health and Disease

Volumn , Issue , 2012, Pages 171-182

  Keppler, Dietrich ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896114627     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (88)

1. Jedlitschky G, Leier I, Buchholz U, et al. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem. J. 1997;327:305-10.
2. Kamisako T, Leier I, Cui Y, et al. Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology 1999;30:485-90.
3. Kartenbeck J, Leuschner U, Mayer R, et al. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996;23:1061-6.
4. Lee YM, Cui Y König J, et al. Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3). Pharmacogenetics 2004;14:213-23.
5. König J, Cui Y, Nies AT, et al. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am. J. Physiol. Gastrointest. Liver Physiol. 2000;278:G156-64.
6. Cui Y, König J, Leier I, et al. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J. Biol. Chem. 2001;276:9626-30.
7. Nies AT, Keppler D. The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch.-Eur. J. Physiol. 2007;453:643-59.
8. Cui Y, König J, Buchholz J, et al. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol. 1999;55:929-37.
9. Cui Y, König J, Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol. Pharmacol. 2001;60:934-43.
10. Letschert K, Komatsu M, Hummel-Eisenbeiss J, et al. Vectorial transport of the peptide CCK-8 by double-transfected MDCKII cells stably expressing the organic anion transporter OATP1B3 (OATP8) and the export pump ABCC2. J. Pharmacol. Exp. Ther. 2005;313:549-56.
11. de Waart DR, Hausler S, Vlaming ML, et al. Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein. J. Pharmacol. Exp. Ther. 2010;334:78-86.
12. Cantz T, Nies AT, Brom M, et al. MRP2, a human conjugate export pump, is present and transports Fluo-3 into apical vacuoles of HepG2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2000;278:G522-31.
13. Hooijberg JH, Broxterman HJ, Kool M, et al. Antifolate resistance mediated by the multi-drug resistance proteins MRP1 and MRP2. Cancer Res. 1999;59:2532-5.
14. Jansen PLM, Peters WHM, Lamers WH. Hereditary chronic conjugated hyperbilirubinemia in mutants rats caused by defective hepatic anion transport. Hepatology 1985;5:573-9.
15. Huber M, Guhlmann A, Jansen PL, et al. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. Hepatology 1987;7:224-8.
16. Oude Elferink RPJ, Meijer DKF, Kuipers F, et al. Hepatobiliary secretion of organic compounds: Molecular mechanisms of membrane transport. Biochim. Biophys. Acta 1995;1241:215-68.
17. Paulusma CC, Bosma PJ, Zaman GJR, et al. Congenital jaundice in rats with a mutation in a multidrug resistance associated-protein gene. Science 1996;271:1126-8.
18. Büchler M, König J, Brom M, et al. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMRP, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J. Biol. Chem. 1996;271:15091-8.
19. Ito K, Suzuki H, Hirohashi T, et al. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am. J. Physiol. 1997;272:G16-22.
20. König J, Nies AT, Cui Y, et al. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta 1999;1461:377-94.
21. Mayer R, Kartenbeck J, Büchler M, et al. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J. Cell Biol. 1995;131:137-50.
22. Taniguchi K, Wada M, Kohno K, et al. A human canalicular multispecific organic anion transporter (cMOAT) overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 1996;56:4124-29.
23. Paulusma CC, Kool M, Bosma PJ, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997;25:1539-42.
24. Evers R, Kool M, van Deemter L, et al. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 1998;101:1310-19.
25. National center for biotechnology information (accessed December 15, 2011, at http://www.ncbi.nlm.nih.gov/gene?term=abcc2).
26. Hagmann W, Nies AT, König J, et al. Purification of the human apical conjugate export pump MRP2. Reconstitution and functional characterization as substrate-stimulated ATPase. Eur. J. Biochem. 1999;265:281-9.
27. Hagmann W, Schubert J, König J, et al. Reconstitution of transport-active multidrug resistance protein 2 (MRP2; ABCC2) in proteoliposomes. Biol. Chem. 2002;383:1001-9.
28. Keppler D, Kartenbeck J. The canalicular conjugate export pump encoded by the cmrp/cmoat gene. In: Boyer JL, Ockner RK, eds. Progress in Liver Diseases. Vol. 14. Philadelphia: Saunders, 1996:55-67.
29. Schaub TP, Kartenbeck J, König J, et al. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J. Am. Soc. Nephrol. 1997;8:1213-21.
30. Schaub TP, Kartenbeck J, König J, et al. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal-cell carcinoma. J. Am. Soc. Nephrol. 1999;10:1159-69.
31. Fromm MF, Kauffmann HM, Fritz P, et al. The effect of rifampin treatment on intestinal expression of human MRP transporters. Am. J. Pathol. 2000;157:1575-80.
32. Sandusky GE, Mintze KS, Pratt SE, et al. Expression of multidrug resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarrays. Histopathology 2002;41:65-74.
33. Rost D, König J, Weiss G, et al. Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. Gastroenterology 2001;121:1203-8.
34. St-Pierre MV, Serrano MA, Macias RI, et al. Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000;279:R1495-503.
35. Nies AT. The role of membrane transporters in drug delivery to brain tumors. Cancer Letters 2007;254:11-29.
36. Berk PD, Howe RB, Bloomer JR, et al. Studies of bilirubin kinetics in normal adults. J. Clin. Invest. 1969;48:2176-90.
37. h ed. Philadelphia: Lippincott, 2001:291-309.
38. Sedlak TW, Saleh M, Higginson DS, et al. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc. Natl. Acad. Sci. USA 2009;106:5171-6.
39. Arias IM, Johnson L, Wolfson S. Biliary excretion of injected conjugated and unconju-gated bilirubin by normal and Gunn rats. Am. J. Physiol. 1961;200:1091-4.
40. Schmid R, Hammaker L. Metabolism and disposition of C14-bilirubin in congenital non-hemolytic jaundice. J. Clin. Invest. 1963;42:1720-34.
41. Fujiwara R, Chen S, Karin M, et al. Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF- B leads to hyperbilirubinemia. Gastroenterology 2012;142:109-18.
42. Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology 2004;40:827-35.
43. McDonagh AF. Controversies in bilirubin biochemistry and their clinical relevance. Semin. Fetal Neonatal Med. 2010;15:141-7.
44. Zucker SD, Goessling W, Hoppin AG. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J. Biol. Chem. 1999;274:10852-62.
45. Briz O, Serrano MA, Macias RI, et al. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem. J. 2003;371:897-905.
46. Zhang W, He YJ, Gan Z, et al. OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation. Clin. Exp. Pharmacol. Physiol. 2007;34:1240-4.
47. Sanna S, Busonero F, Maschio A, et al. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum. Mol. Genet. 2009;18:2711-18.
48. Johnson AD, Kavousi M, Smith AV, et al. Genome-wide association meta-analysis for total serum bilirubin levels. Hum. Mol. Genet. 2009;18:2700-10.
49. van de Steeg E, Wagenaar E, van der Kruijssen CM, et al. Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J. Clin. Invest. 2010;120:2942-52.
50. van de Steeg E, Stranecky V, Hartmannova H, et al. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J. Clin. Invest. 2012;122:519-28.
51. Hagenbuch B, Gui C. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 2008;38:778-801.
52. Mackenzie PI, Bock KW, Burchell B, et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genomics 2005;15:677-85.
53. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 2000;40:581-616.
54. König J, Rost D, Cui Y, et al. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999;29:1156-63.
55. Rost D, Mahner S, Sugiyama Y, et al. Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2002;282:G720-6.
56. Akita H, Suzuki H, Hirohashi T, et al. Transport activity of human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharm. Res. 2002;19:34-41.
57. Scheffer GL, Kool M, de Haas M, et al. Tissue distribution and induction of human multidrug resistant protein 3. Lab. Invest. 2002;82:193-201.
58. Borst P, de Wolf C, van de Wetering K. Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch. 2007;453:661-73.
59. Rius M, Hummel-Eisenbeiss J, Hofmann AF, et al. Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. Am. J. Physiol. Gastrointest. Liver Physiol. 2006;290:G640-9.
60. König J. Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms. In: Fromm MF, Kim RB, eds. Drug Transporters. Handb. Exp. Pharmacol., vol. 201, Heidelberg: Springer, 2011:1-28.
61. Degorter MK, Xia CQ, Yang JJ, et al. Drug transporters in drug efficacy and toxicity. Annu. Rev. Pharmacol. Toxicol. 2012;52:249-73.
62. Zucker SD, Qin X, Rouster SD, et al. Mechanism of indinavir-induced hyperbilirubine-mia. Proc. Natl. Acad. Sci. USA. 2001;98:12671-6.
63. Lankisch TO, Behrens G, Ehmer U, et al. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy-an extended haplotype of genetic variants increases risk in indinavir treatment. J. Hepatol. 2009;50:1010-18.
64. Campbell SD, de Morais SM, Xu JJ. Inhibition of human organic anion transporting poly-peptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia. Chem. Biol. Interact. 2004;150:179-87.
65. Campbell SD, Lau WF, Xu JJ. Interaction of porphyrins with human organic anion transporting polypeptide 1B1. Chem. Biol. Interact. 2009;182:45-51.
66. Dubin IN, Johnson FB. Chronic idiopathic jaundice with unidentified pigment in liver cells; a new clinicopathologic entity with report of 12 cases. Medicine (Baltimore) 1954;33:155-79.
67. Sprinz H, Nelson RS. Persistent nonhemolytic hyperbilirubinemia associated with lipo-chrome-like pigment in liver cells; report of four cases. Ann. Intern. Med. 1954;41:952-62.
68. Shani M, Seligsohn U, Gilon E, et al. Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases. Quarterly J. Med. 1970;39:549-67.
69. Kajihara S, Hisatomi A, Mizuta T, et al. A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome. Biochem. Biophys. Res. Commun. 1998;253:454-7.
70. Toh S, Wada M, Uchiumi T, et al. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am. J. Hum. Genet. 1999;64:739-46.
71. Mor-Cohen R, Zivelin A, Rosenberg N, et al. Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J. Biol. Chem. 2001;276:36923-30.
72. Tsujii H, König J, Rost D, et al. Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome. Gastroenterology 1999;117:653-60.
73. Thermann R, Neu-Yilik G, Deters A, et al. Binary specifications of nonsense codons by splicing and cytoplasmic translation. EMBO J. 1998;17:3484-94.
74. Keitel V, Kartenbeck J, Nies AT, et al. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 2000;32:1317-28.
75. Keitel V, Nies AT, Brom M, et al. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). Am. J. Physiol. Gastrointest. Liver Physiol. 2003;284:G165-74.
76. Kikuchi S, Hata M, Fukumoto K, et al. Radixin deficiency causes conjugated hyper-bilirubinemia with loss of Mrp2 from bile canalicular membranes. Nature Genet. 2002;31:320-5.
77. Kojima H, Nies AT, König J, et al. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J. Hepatol. 2003;39:693-702.
78. Beuers U, Bilzer M, Chittattu A, et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 2001;33:1206-16.
79. Roelofsen H, Soroka CJ, Keppler D, et al. Cyclic AMP stimulates sorting of the canalicular organic anion transporter (Mrp2/cMoat) to the apical domain in hepatocyte couplets. J. Cell Sci. 1998;111:1137-45.
80. Trauner M, Arrese M, Soroka CJ, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255-64.
81. Mottino AD, Cao J, Veggi LM, et al. Altered localization and activity of canalicular Mrp2 in estradiol-17beta-D-glucuronide-induced cholestasis. Hepatology 2002;35:1409-19.
82. Rost D, Kartenbeck J, Keppler D. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology 1999;29:814-21.
83. Dombrowski F, Kubitz R, Chittattu A, et al. Electron-microscopic demonstration of multi-drug resistance protein 2 (Mrp2) retrieval from the canalicular membrane in response to hyperosmolarity and lipopolysaccharide. Biochem. J. 2000;348:183-8.
84. Kubitz R, D'Urso D, Keppler D, et al. Osmodependent dynamic localization of the multidrug resistance protein 2 in the rat hepatocyte canalicular membrane. Gastroenterology 1997;113:1438-42.
85. Cantore M, Reinehr R, Sommerfeld A, et al. The Src family kinase Fyn mediates hyperosmolarity-induced Mrp2 and Bsep retrieval from canalicular membrane. J. Biol. Chem. 2011; 286:45014-29.
86. Zollner G, Fickert P, Zenz R, et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 2001;33:633-46.
87. Shoda J, Kano M, Oda K, et al. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am. J. Gastroenterol. 2001;96:3368-78.
88. Yamada T, Arai T, Nagino M, et al. Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer. Langenbecks Arch. Surg. 2005;390:421-9.